TLDR Latanoprost may cause scalp inflammation and delayed healing.
The article reports a case of a 61-year-old woman who developed erosive pustular dermatosis of the scalp (EPDS) after using topical latanoprost for androgenetic alopecia. EPDS is an inflammatory chronic disease that leads to scarring alopecia. Although trauma is known to precipitate this condition, topical latanoprost has not previously been reported as a triggering factor. The authors suggest that EPDS should be considered in any subject developing a chronic inflammatory response or delayed healing after latanoprost treatment. More research is needed to determine the efficacy and safety of latanoprost or other prostaglandin analogs for hair growth.
Cited in this study
2 / 2 results
81 citations
,
May 2012 in “Journal of The American Academy of Dermatology” Latanoprost 0.1% may effectively treat hair loss.
52 citations
,
March 2009 in “Journal of the American Academy of Dermatology” A 93-year-old woman developed a rare scalp condition after therapy, which improved with steroids, not antibiotics.
September 2020 in “Journal of Cutaneous Pathology” A patient with a skin condition had unusual scarring hair loss but improved with treatment.
A 21-year-old with lichen planopilaris was successfully treated, stopping disease progression and preventing crusts.
5 citations
,
July 2018 in “Skin appendage disorders” Sunscreen spray on the scalp may be linked to a type of scarring hair loss.
4 citations
,
July 2015 in “Case Reports in Dermatology” A woman with unexplained hair loss was found to have harmless skin tumors and a scarring hair loss condition, but the tumors didn't cause the hair loss.
21 citations
,
March 2015 in “Dermatologic Therapy” Latanoprost may cause scalp inflammation and delayed healing.